Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 5/20 | 0.62 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.62 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.62 |
| ▸ | CD209 | Q9NNX6 | 2/20 | 0.50 |
| ▸ | ENGASE | Q8NFI3 | 1/20 | 0.49 |
| ▸ | AMY2A | P04746 | 2/20 | 0.49 |
| ▸ | CD69 | Q07108 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.47 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.47 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.47 |
| ▸ | HPSE | Q9Y251 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31701301 | 1.00 | LGALS3 (0.62) | LGALS3LGALS8LGALS4CD209ENGASE | |
| SCHEMBL31701585 | 1.00 | LGALS3 (0.62) | LGALS3LGALS8LGALS4CD209ENGASE | |
| SCHEMBL31701557 | 1.00 | LGALS3 (0.62) | LGALS3LGALS8LGALS4CD209ENGASE | |
| SCHEMBL31701506 | 1.00 | LGALS3 (0.62) | LGALS3LGALS8LGALS4CD209ENGASE | |
| SCHEMBL31700358 | 1.00 | LGALS3 (0.62) | LGALS3LGALS8LGALS4CD209ENGASE | |
| SCHEMBL31700471 | 1.00 | LGALS3 (0.62) | LGALS3LGALS8LGALS4CD209ENGASE | |
| SCHEMBL31701119 | 1.00 | LGALS3 (0.62) | LGALS3LGALS8LGALS4CD209ENGASE | |
| SCHEMBL31700355 | 1.00 | LGALS3 (0.62) | LGALS3LGALS8LGALS4CD209ENGASE | |
| SCHEMBL31701568 | 1.00 | LGALS3 (0.62) | LGALS3LGALS8LGALS4CD209ENGASE | |
| SCHEMBL31701588 | 1.00 | LGALS3 (0.62) | LGALS3LGALS8LGALS4CD209ENGASE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1825 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260139285-A1 | SACCHARIDE IMPORTERS FOR LACTO-N-TRIOSE | INBIOSE N V (BE) | 2026-05-21 | — | — | US | claimed |
| EP-4742901-A1 | METHOD TO IMPROVE A PLANT'S GROWTH, DEVELOPMENT AND RESISTANCE TO (A)BIOTIC STRESS | Globachem NV (BE) | 2026-05-20 | — | — | EP | claimed |
| CN-122030617-A | Composition for improving stool consistency or frequency of infants or young children | 雀巢产品有限公司 | 2026-05-15 | — | — | CN | claimed |
| US-20260062726-A1 | HYBRID METHOD FOR PRODUCING COMPLEX HMOS | DSM IP ASSETS BV (NL) | 2026-03-05 | — | — | US | claimed |
| US-20260015637-A1 | SIGMA FACTOR MODIFICATIONS FOR BIOSYNTHETIC PRODUCTION | DSM IP ASSETS BV (NL) | 2026-01-15 | — | — | US | claimed |
| US-20250382649-A1 | CELLS WITH TRI-, TETRA- OR PENTASACCHARIDE IMPORTERS USEFUL IN OLIGOSACCHARIDE PRODUCTION | DSM IP ASSETS BV (NL) | 2025-12-18 | — | — | US | claimed |
| EP-4662305-A1 | PRODUCTION OF A DISACCHARIDE AND/OR MILK OLIGOSACCHARIDE BY A CELL WITH REDUCED SYNTHESIS OF UDP-GLCNAC | Inbiose N.V. (BE) | 2025-12-17 | — | — | EP | claimed |
| EP-4662224-A1 | PRODUCTION OF A SACCHARIDE BY A CELL WITH REDUCED SYNTHESIS OF LACTOBIONIC ACID | Inbiose N.V. (BE) | 2025-12-17 | — | — | EP | claimed |
| US-20250376707-A1 | SEPARATION OF HUMAN MILK OLIGOSACCHARIDES FROM A FERMENTATION BROTH | DSM IP ASSETS BV (NL) | 2025-12-11 | — | — | US | claimed |
| US-20250361256-A1 | SEPARATION OF HUMAN MILK OLIGOSACCHARIDES FROM A FERMENTATION BROTH | DSM IP ASSETS BV (NL) | 2025-11-27 | — | — | US | claimed |
| US-20080220988-A1 | Preparing carbohydrate microarrays and conjugated nanoparticles | ADA TECHNOLOGIES, INC. (US) | 2008-09-11 | — | — | US | claimed |
| CN-101213157-A | Apparatus and method for manure reclamation | TIMOTHY CAMISA (US) | 2008-07-02 | — | — | CN | claimed |
| EP-1890984-A2 | APPARATUS AND METHOD FOR MANURE RECLAMATION | Camisa, Timothy (US) | 2008-02-27 | — | — | EP | claimed |
| WO-2006138383-A2 | APPARATUS AND METHOD FOR MANURE RECLAMATION | CAMISA TIMOTHY (US) | 2006-12-28 | — | — | WO | claimed |
| US-20060283221-A1 | Apparatus and method for manure reclamation | VERMONT ORGANICS RECLAMATION INC. | 2006-12-21 | — | — | US | claimed |
| US-20050019874-A1 | Processes for producing sugar nucleotides and complex carbohydrates | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2005-01-27 | — | — | US | claimed |
| US-20020064836-A1 | PROCESSES FOR PRODUCING SUGAR NUCLEOTIDES AND COMPLEX CARBOHYDRATES | KYOWA HAKKO BIO CO., LTD. (JP) | 2002-05-30 | — | — | US | claimed |
| WO-2002032963-A1 | IMMUNOADJUVANT SYSTEMS | ALCHEMIA PTY LTD (AU) | 2002-04-25 | — | — | WO | claimed |
| US-20020025560-A1 | Processes for producing sugar nucleotides and complex carbohydrates | KYOWA HAKKO BIO CO., LTD. (JP) | 2002-02-28 | — | — | US | claimed |
| EP-0870841-A1 | PROCESSES FOR PRODUCING SUGAR NUCLEOTIDES AND COMPLEX CARBOHYDRATES | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1998-10-14 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250361256-A1 | SEPARATION OF HUMAN MILK OLIGOSACCHARIDES FROM A FERMENTATION BROTH | FUT6, FUT5, ST3GAL3 | LGALS3 266/4885LGALS8 705/4885LGALS4 160/4885 |
| US-20260062726-A1 | HYBRID METHOD FOR PRODUCING COMPLEX HMOS | FUCA1, GMDS, MANBA | LGALS3 985/4885LGALS8 921/4885LGALS4 841/4885 |
| US-20260139285-A1 | SACCHARIDE IMPORTERS FOR LACTO-N-TRIOSE | GALNT3, NANS, ENGASE | LGALS3 13/4885LGALS8 72/4885LGALS4 24/4885 |
| US-20260015637-A1 | SIGMA FACTOR MODIFICATIONS FOR BIOSYNTHETIC PRODUCTION | RNGTT, PURB, SLTM | LGALS3 3261/4885LGALS8 4215/4885LGALS4 3641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.